MCULE-1926897732
- InChIKey:
- SMILES:
- InChI:
- Formula:
Amount | Price
Optimized compound price excluding delivery costs. Please note that automatic quote generation will optimize the total price based on your preferences.
|
Guaranteed purity (%) | Delivery time
Estimated door-to-door delivery time for EU and US customers. It will be refined and optimized during quote generation after the shipping country is specified.
|
|
---|---|---|---|---|
1 mg | 7 USD | N/A | 9 working days | Get Quote |
5 mg | 7 USD | N/A | 9 working days | Get Quote |
10 mg | 7 USD | N/A | 9 working days | Get Quote |
- 1-Click Docking Predict the binding orientation and affinity of the ligand to a target.
- Toxicity checker Searching for substructures commonly found in toxic and promiscuous ligands.
- Property calculator Create a physicochemical property profile for the compound in a second.
- Similarity search Find analogs by similarity search.
- Substructure search Find analogs by substructure search.
-
1
MCULE-2723514398
- Component type: Main
-
1
MCULE-5133077095
- Component type: Counter Ion
Name | File |
---|---|
SDF | MCULE-1926897732.sdf |
SMILES | MCULE-1926897732.smiles |
Standard InChI | MCULE-1926897732.inchi |
InChIKey | MCULE-1926897732.txt |
mcule product ID | Supplier | Catalog | Guaranteed purity (%) | Product matching | Availability |
---|---|---|---|---|---|
P-893243235 | Biosynth | In Stock | 95 | As is | in stock |
P-892303159 | TargetMol | Natural Products | 95 | As is | in stock |
P-869152777 | TargetMol | Screening Compounds - synthesis | 95 | As is | by synthesis |
P-888651406 | TargetMol | Screening Compounds - stock amount | 95 | As is | unavailable |
P-854973129 | Toronto Research | In stock | 90 | As is | in stock |
P-893132116 | A2B Chem | Predominantly Building Block on demand | N/A | Main component as a main component | by synthesis |
P-893138600 | A2B Chem | Predominantly Building Block on demand | N/A | Main component as a main component | by synthesis |
P-867676817 | A2B Chem | Predominantly Building Block in stock | 98 | Main component as a main component | in stock |
P-875853222 | AA Blocks | AA Blocks - in stock | N/A | Main component as a main component | in stock |
P-851926420 | AmBeed | In stock | N/A | Main component as a main component | in stock |
P-596934263 | Angene | Building Blocks in stock | 99 | Main component as a main component | 1000 g |
P-881654727 | Apexbio Technology | Bioactive Compound Library | 98 | Main component as a main component | in stock |
P-864158507 | AstaTech | In Stock BBs | 95 | Main component as a main component | in stock |
P-868545931 | Axon Medchem | Axon predominantly SC catalog | 98 | Main component as a main component | in stock |
P-675214203 | Hangzhou Apichem | Building Blocks in stock | 95 | Main component as a main component | in stock |
P-892250541 | TargetMol | Screening Compounds - synthesis | 95 | Main component as a main component | by synthesis |
P-594275174 | TargetMol | Screening Compounds - synthesis | 95 | Main component as a main component | by synthesis |
P-892336114 | TargetMol | Screening Compounds - stock amount | 95 | Main component as a main component | unavailable |
P-892296934 | TargetMol | In Stock BB | 95 | Main component as a main component | 881 mg |
P-892340657 | TargetMol | Screening Compounds - stock amount | 95 | Main component as a main component | 881 mg |
P-855299342 | Toronto Research | In stock | 90 | Main component as a main component | in stock |
Property | Value |
---|---|
Components | 2 |
Mass | 404.318 |
logP | -0.483 |
H-bond acceptors | 10 |
H-bond donors | 4 |
Rotatable bonds | 4 |
PSA | 182.47 |
RO5 violations | 0 |
RO3 violations | 5 |
Refractivity | 75.6087 |
Atoms | 41 |
Rings | 2 |
Heavy atoms | 26 |
Hydrogen atoms | 15 |
Heteroatoms | 14 |
N/O atoms | 10 |
Inorganic atoms | 0 |
Halogen atoms | 3 |
Chiral centers | 4 |
R/S chiral centers | 4 |
Unknown chiral centers | 0 |
Undefined chiral centers | 0 |
Stereo double bonds | 0 |
Cis/trans stereo double bonds | 0 |
Unknown stereo double bonds | 0 |
Undefined stereo double bonds | 0 |